机构:[1]MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China[2]Department of Chemistry, Jinan University, Guangzhou 510632, China[3]Beijing Tongren Hospital, Capital Medical University, Beijing 100730, China.首都医科大学附属北京同仁医院临床科室胸外科
National Key Research
and Development Program of China (No. 2022YFA1103900) and NSFC
(81972778) to L.C., GuangDong Basic and Applied Basic Research Foundation
(2021A1515010461) to Q.Z., GuangZhou Basic, Applied Basic Research
Foundation (202102020512) to Q.Z., The Fundamental Research Funds for the
Central Universities (21619101) to L.C., NSFC (31800723) to Q.Z.
第一作者机构:[1]MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou 510632, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
Liu Lu,Lei Yuxi,Chen Wensheng,et al.In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer[J].CELL AND BIOSCIENCE.2022,12(1):doi:10.1186/s13578-022-00933-0.
APA:
Liu Lu,Lei Yuxi,Chen Wensheng,Zhou Qian,Zheng Zongyao...&Chen Liang.(2022).In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer.CELL AND BIOSCIENCE,12,(1)
MLA:
Liu Lu,et al."In vivo genome-wide CRISPR screening identifies ZNF24 as a negative NF-κB modulator in lung cancer".CELL AND BIOSCIENCE 12..1(2022)